Why Fellows Choose Penn Medicine
Penn Hematology/Oncology offers outstanding fellowship training programs in clinical and investigative areas. Penn’s program attracts fellowship applicants from top-ranked universities throughout the world who are interested in careers in academic medicine.
Penn Hematology/Oncology offers:
- Fellowship programs designed to provide participants the foundation for lifelong careers in clinical practice and research.
- Program directors who are dedicated to the development, guidance and mentoring of fellows.
- The opportunity to train in a wide variety of laboratories within the University of Pennsylvania, Abramson Cancer Center, Children's Hospital of Philadelphia and Wistar Institute
- The NHLBI K12 Program, the purpose of which is to develop, implement and evaluate multidisciplinary career development programs in non-malignant hematology. Penn is one of the few programs in the country to offer this program.
- A collaborative practice and research environment that fosters productive interactions among fellow trainees and physicians from other medical disciplines and faculty from other departments within the University.
- High recruitment rates of fellows for leadership positions in academic medicine and private practice.
Penn's division of hematology/oncology offers a three-year combined fellowship in hematology and medical oncology which provides outstanding training that is balanced amongst all realms including solid tumors, hematologic malignancies, blood and marrow transplantation, and benign or 'classical' hematology.
Our fellowship instills excellence in both the clinical and the investigative arenas. Our aim is to produce pioneering thinkers, top-notch clinicians, and investigative innovators who will become the next generation of leaders in academic hematology and medical oncology.
The hematology/oncology fellowship at the University of Pennsylvania offers the opportunity to learn in a unique and vibrant environment, allowing talented and motivated individuals to gain skill sets that position them to become leaders in the field of hematology/oncology.
Fellows receive clinical training through a wide range of experiences in benign hematology, hematologic malignancies and stem cell transplantation, and solid tumor oncology, as well as research training in one of several settings.
Classical (Non-Malignant) Hematology Program
The benign hematology program is currently supported by NIH-funded research training grants in hematology, oncology, pathology and epidemiology.
Penn's division of hematology/oncology is home to several NIH institutional career development awards (K12) to facilitate the transition from fellowship to junior faculty. Members of the training program currently receive more than $40 million in research support from external agencies.